Granulocyte Colony-Stimulating Factor Treatment During Radiotherapy Is Associated With Survival Benefit in Patients With Lung Cancer

OBJECTIVES: Granulocyte colony-stimulating factor, an agent commonly used for neutropenia treatment, plays an important role in cancer treatment. However, the effect of granulocyte colony-stimulating factor treatment on patient’s survival during radiation therapy in lung cancer remains unknown. MATE...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Rui, Hu, Pingping, Liu, Qiqi, Zhang, Jingxin, Deng, Guodong, Hu, Dan, Zhang, Jiandong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295692/
https://www.ncbi.nlm.nih.gov/pubmed/31122176
http://dx.doi.org/10.1177/1533033818816076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295692/
https://www.ncbi.nlm.nih.gov/pubmed/31122176
http://dx.doi.org/10.1177/1533033818816076

Ejemplares similares